Clinical trial

BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy

NCT05363644

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2023-04-01

PhasePHASE3

Study timeline

Study start (estimated)2023-04-01Date precision: day

Registry last updated2023-06-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Prostatectomyunresolved

Erectile Dysfunction Following Radical Prostatectomyunresolved

Incontinence, Urinaryunresolved

Interventions

BioDFence G3BIOLOGICAL

Sponsors & collaborators

AdventHealthlead sponsor

Integra LifeSciences Corporationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05363644 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.